ArticleFrontiers in public health2026
Global, regional, and national trends in hypertensive heart disease burden due to high BMI: a 30-year analysis using GBD 2021 data with projections to 2035.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High body mass index (BMI)-related hypertensive heart disease (HHD) is increasingly prevalent worldwide. Using Global Burden of Disease (GBD) 2021 data, we analyzed the changes in disability-adjusted life years (DALYs) and age-standardized rate (ASR) of mortality (ASMR) due to high BMI from 1990 to 2021. Methods: HHD data on high BMI were obtained from GBD 2021 at global, regional, and country levels. Age-standardized DALYs (ASDR) and deaths (ASMR) were calculated, with trends analyzed based on gender, age, and region. The autoregressive integrated moving average (ARIMA) model was used to project the burden through 2035, while the estimated annual percentage change (EAPC) was used to assess future trends. Results: From 1990 to 2021, global DALYs increased from 5.67 million to 12.55 million (a 1.81% rise in ASR), and deaths rose from 240,000 to 594,000. Men showed an 8.28% increase in DALYs, while women's burden remained stable with a slight ASR decline. The highest burden was observed in those aged 80 and older, with DALYs increasing from 1243.80 to 1604.32. Projections suggest gradual decreases in DALYs and ASMR by 2035, although high BMI-related HHD remains a major public health concern. Conclusion: High BMI intensifies HHD prevalence, particularly among men and older adults. Despite projected minor decreases by 2035, rising obesity underscores the ongoing need for public health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.